An alphavirus-based therapeutic cancer vaccine: from design to clinical trial.

MLA

Singh, Amrita, et al. “An Alphavirus-Based Therapeutic Cancer Vaccine: From Design to Clinical Trial.” Cancer Immunology, Immunotherapy, vol. 68, no. 5, May 2019, pp. 849–59. EBSCOhost, https://doi.org/10.1007/s00262-018-2276-z.

APA

Singh, A., Koutsoumpli, G., van de Wall, S., & Daemen, T. (2019). An alphavirus-based therapeutic cancer vaccine: from design to clinical trial. Cancer Immunology, Immunotherapy, 68(5), 849–859. https://doi.org/10.1007/s00262-018-2276-z

Chicago

Singh, Amrita, Georgia Koutsoumpli, Stephanie van de Wall, and Toos Daemen. 2019. “An Alphavirus-Based Therapeutic Cancer Vaccine: From Design to Clinical Trial.” Cancer Immunology, Immunotherapy 68 (5): 849–59. doi:10.1007/s00262-018-2276-z.